Monday 5 March 2012

Humatin



paromomycin sulfate

Dosage Form: capsules

Description


Humatin is a broad spectrum antibiotic produced by Streptomyces rimosus var. paromomycinus. It is a white, amorphous, stable, water-soluble product supplied as capsules containing the equivalent of 250 mg paromomycin.


The capsule contains D&C yellow No. 10; FD&C blue No. 1; FD&C red No. 3; FD&C yellow No. 6; gelatin, NF; and titanium dioxide, USP.



Action


The in vitro and in vivo antibacterial action of paromomycin closely parallels that of neomycin. It is poorly absorbed after oral administration, with almost 100% of the drug recoverable in the stool.



Indications


Humatin is indicated for intestinal amebiasis––acute and chronic (NOTE ––It is not effective in extraintestinal amebiasis); management of hepatic coma––as adjunctive therapy.



Contraindications


Paromomycin sulfate is contraindicated in individuals with a history of previous hypersensitivity reactions to it. It is also contraindicated in intestinal obstruction.



Precautions


The use of this antibiotic, as with other antibiotics, may result in an overgrowth of nonsusceptible organisms, including fungi. Constant observation of the patient is essential. If new infections caused by nonsusceptible organisms appear during therapy, appropriate measures should be taken.


The drug should be used with caution in individuals with ulcerative lesions of the bowel to avoid renal toxicity through inadvertent absorption.


Pediatric Use: See Dosage and Administration section.



Adverse Reactions


Nausea, abdominal cramps, and diarrhea have been reported in patients on doses over 3 g daily.



Dosage and Administration


Intestinal amebiasis: Adults and Pediatric Patients: Usual dose––25 to 35 mg/kg body weight daily, administered in three doses with meals, for five to ten days.


Management of hepatic coma: Adults: Usual dose––4 g daily in divided doses, given at regular intervals for five to six days.



How Supplied


Humatin Capsules, each containing paromomycin sulfate equivalent to 250 mg paromomycin, are supplied as follows


NDC 61570-529-10: Bottles of 100


Store at controlled room temperature 15°–30°C (59°–86°F).


Protect from moisture.


Rx only.


Prescribing Information as of November 2001.


Distributed by: Monarch Pharmaceuticals, Inc., Bristol, TN 37620


Manufactured by: Caraco Pharmaceutical Laboratories, Ltd., Detroit, MI 48202








Humatin 
paromomycin sulfate  capsule










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)61570-529
Route of AdministrationORALDEA Schedule    


























INGREDIENTS
Name (Active Moiety)TypeStrength
Paromomycin Sulfate (Paromomycin)Active250 MILLIGRAM  In 1 CAPSULE
D&C yellow No. 10Inactive 
FD&C blue No. 1Inactive 
FD&C red No. 3Inactive 
FD&C yellow No. 6Inactive 
gelatinInactive 
titanium dioxideInactive 






















Product Characteristics
ColorYELLOWScoreno score
ShapeCAPSULESize19mm
FlavorImprint Code
Contains      
CoatingfalseSymbolfalse










Packaging
#NDCPackage DescriptionMultilevel Packaging
161570-529-10100 CAPSULE In 1 BOTTLENone

Revised: 03/2007Monarch Pharmaceuticals, Inc.

More Humatin resources


  • Humatin Side Effects (in more detail)
  • Humatin Dosage
  • Humatin Use in Pregnancy & Breastfeeding
  • Drug Images
  • Humatin Drug Interactions
  • Humatin Support Group
  • 1 Review for Humatin - Add your own review/rating


  • Humatin Concise Consumer Information (Cerner Multum)

  • Humatin MedFacts Consumer Leaflet (Wolters Kluwer)

  • Humatin Advanced Consumer (Micromedex) - Includes Dosage Information

  • paromomycin Concise Consumer Information (Cerner Multum)

  • Paromomycin Sulfate Monograph (AHFS DI)



Compare Humatin with other medications


  • Amebiasis
  • Cryptosporidiosis
  • Dientamoeba fragilis
  • Dog Tapeworm
  • Fish Tapeworm Infection
  • Giardiasis
  • Hepatic Coma
  • Hymenolepis nana, Dwarf Tapeworm
  • Taenia saginata, beef tapeworm
  • Taenia solium, pork tapeworm

No comments:

Post a Comment